University of Queensland, CEPI and CSL partnered to advance development of COVID-19 vaccine candidate
On Jun. 5, 2020, CEPI, the Coalition for Epidemic Preparedness Innovations, CSL and The University of Queensland (UQ)…
-
-
University of British Columbia scientist identified a gene that controls thinness
On May 21, 2020, in a study published in the journal Cell, Life Sciences Institute Director Dr. Josef…
-
Biotechnology | Disease | FDA | Oncology | Therapeutics
FDA approved first new drug under international collaboration for patients with HER2-positive metastatic breast cancer
On Apr. 17, 2020, as part of Project Orbis, the U.S. Food and Drug Administration (FDA) approved Seagen’s…
-
CHF Solutions doubled production staff of Aquadex SmartFlow consoles due to hospital demand
On Apr. 2, 2020, CHF Solutions announced it has doubled the production staff that builds its next generation…
-
Golden Rice Approved by U.S. FDA
On May 24, 2018, the U.S. Food and Drug Administration (FDA) released a statement on GR2E Golden Rice,…
-
Researchers unlock genetic code of cancer-causing liver fluke parasite
On Sept. 10, 2014, an international team of scientists from Singapore, Thailand, China and Australia announced that they…
-
Biotechnology | FDA | Vaccine
FDA expanded age indication for Menveo to include infants and toddlers age 2 through 23 months
On Aug. 1, 2013, Novartis announced the U.S. Food and Drug Administration (FDA) had approved Menveo (Meningococcal [Groups…
-
Genome for endangered Tasmanian tiger was completed
On Jun. 28, 2011, to prevent extinction of the Tasmanian tiger, a team of scientists led by the…
-
Agriculture | Biotechnology | Diagnostics | Infectious Disease | Influenza | Vaccine | WHO
Australia approved locally made bird flu vaccine
On Jun. 15, 2008, Australia announced it had approved the first locally made vaccine to protect humans from…
-
FDA approved Afluria, a new inactivated influenza vaccine for use in people age 18 years and older
On Sept. 28, 2007, the U.S. Food and Drug Administration (FDA) approved an Australian-made influenza vaccine called Afluria…
-
Corus Pharma was acquired by Gilead Sciences for $365 million
On Aug. 11, 2006, Gilead Sciences announced that it had completed its acquisition of Corus Pharma for $365…
